By Jennifer Langley
CONMED (NASDAQ:CNMD) is scheduled to be posting its Q315 quarterly earnings results on Wednesday, October 21st. Analysts expect CONMED to post earnings of $0.44 per share and revenue of $173.96 million for the quarter. CONMED has set its FY15 guidance at $1.82-1.92 EPS.Individual that are interested in registering for the company’s earnings conference call
can do so using this link.
CONMED (NASDAQ:CNMD) last issued its quarterly earnings results on Tuesday, July 21st. The medical technology company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.44 by $0.08. During the same period in the previous year, the firm earned $0.47 EPS. The firm earned $181 million during the quarter, compared to analysts’ expectations of $182.40 million. CONMED’s quarterly revenue was down 3.8% on a year-over-year basis. On average, analysts expect CONMED to post $1.83 EPS for the current fiscal year and $2.12 EPS for the next fiscal year.
CNMD has been the topic of several analyst reports. Ladenburg Thalmann upgraded CONMED from a “neutral” rating to a “buy” rating and set a $55.00 target price for the company in a report on Monday, October 12th. Needham & Company LLC reissued a “buy” rating and issued a $60.00 price target on shares of CONMED in a research report on Monday, October 5th. Deutsche Bank reaffirmed a “buy” rating and set a $71.00 target price on shares of CONMED in a research report on Thursday, July 23rd.
